top of page
Krebs
AI-assisted breast-cancer screening may reduce unnecessary testing
Using artificial intelligence (AI) to supplement radiologists’ evaluations of mammograms may improve breast-cancer screening by reducing...
Corax Consultants LLC
11. Apr. 20241 Min. Lesezeit
Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic b
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the approval of the CE Mark for the VENTANA® HER2 (4B5) Rabbit Monoclonal Primary...
Corax Consultants LLC
10. Apr. 20241 Min. Lesezeit
bottom of page